Latest information


Participation in the establishment of a study group to promote and standardize home GA measurement.​

Establishment of OMEGA Study Group​

Glycated Albumin (GA) has been a biomarker only measured in hospital outpatient testing. However, GA is sensitive to changes in blood glucose improvement over the last week, and its benefit can be maximized when it is used as a ‘behavior change measure’ in home-based testing.​

Weekly home GA testing for lifestyle improvement is an unprecedented new concept. It must be standardized as a medical treatment to put it to practical use and contribute to the world.​

For this reason, the OMEGA Study Group has been established by researchers aiming to standardize weekly home GA testing. Provigate has joined the group as a founding member. For more information, please visit the OMEGA Study Group website.​

For further information, please contact:

People may think of glucose monitoring as simple as this: "Diabetes is a disease of blood sugar. This is why people with diabetes use glucometer."
However, it's not that simple. Blood sugar measurement has diverse objectives, including diagnosing diabetes, dosing self-injection of insulin, avoiding hypoglycemia due to excessive drug efficacy, and behavior change.
You must choose the appropriate blood sugar measurement method for your purpose.

There are two types of self-blood glucose measurement methods: SMBG (Self-Monitoring of Blood Glucose), which is widely used, and CGM (Continuous Glucose Monitoring), which has become popular in recent years.
These two blood glucose measurement methods are designed mainly for patients who self-inject insulin and other injectable drugs.
Until now, there has been no simple and daily method for measuring blood glucose at home other than these two methods.

Some drugs, such as insulin, are very potent and can cause dangerous hypoglycemia if the dosage is incorrect.
Therefore, for example, those who use insulin must measure their blood glucose accurately before self-injection at home and carefully determine the dose.
After injection, if there are signs of hypoglycemia, it is necessary to measure blood glucose immediately. If necessary, you need to take some sugar to avoid hypoglycemia.
However, both methods have an issue with invasiveness. In addition, they cost a lot. CGM costs at least $60 and needs to be replaced every two weeks, which is also a significant economic burden. SMBG requires frequent measurements, so the total cost becomes significant when accumulated.
Unfortunately, SMBG and CGM are not suitable for everyone due to invasiveness and cost.



Let’s make significant innovations in the era of the healthcare revolution.
We’re looking for talented and enthusiastic individuals to create a better future for everyone.


Feel free to contact us about our services, recruitment and interviews.

Copyright© Provigate, Inc. All Rights Reserved.